| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | Chief Operating Officer
3 companies
Hunt Anthony is a Director at REPLIGEN CORP with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 48 sells.
Estimated insider holdings value: $12.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | RGEN Repligen Corp | Director | Sale+OE | 20,000 | $154.61 | $3,092,278.36 | -3.1% | -7.4% | - | |
| Nov 12, 2025 | RGEN Repligen Corp | Director | Sale+OE | 25,000 | $156.88 | $3,921,939.67 | -4.3% | -9.5% | - | |
| Sep 10, 2025 | RGEN Repligen Corp | Director | Sale+OE | 29,111 | $120.52 | $3,508,388.91 | -4.0% | +33.6% | - | |
| May 15, 2025 | RGEN Repligen Corp | Director | Sell | 26,447 | $123.71 | $3,271,687.92 | -4.4% | +3.2% | -16.5% | |
| Mar 17, 2025 | RGEN Repligen Corp | Director | Sale+OE | 26,756 | $152.51 | $4,080,663.26 | -2.8% | -17.5% | -21.9% | |
| Nov 21, 2024 | RGEN Repligen Corp | Director | Sale+OE | 24,246 | $139.67 | $3,386,438.82 | -14.8% | +6.3% | +14.6% | |
| Sep 10, 2024 | RGEN Repligen Corp | Director | Sale+OE | 22,191 | $145.37 | $3,225,927.40 | -3.6% | +5.5% | -18.0% | |
| Jun 14, 2024 | RGEN Repligen Corp | Chief Executive Officer | Buy | 2,000 | $124.08 | $248,160.00 | +1.2% | +13.0% | +1.5% | |
| May 21, 2024 | RGEN Repligen Corp | Chief Executive Officer | Sell | 20,072 | $168.26 | $3,377,283.01 | -1.9% | -7.8% | -28.0% | |
| Mar 8, 2024 | RGEN Repligen Corp | Chief Executive Officer | Sale+OE | 16,707 | $197.44 | $3,298,632.04 | -1.1% | -24.0% | -20.3% |